Jia S, Chen Q, Huang W, Wang P, Zeng Y
Sci Rep. 2025; 15(1):7887.
PMID: 40050308
PMC: 11885421.
DOI: 10.1038/s41598-025-90947-8.
Deng J, Wei L, Chen Y, Li X, Zhang H, Wei X
BMC Pharmacol Toxicol. 2025; 26(1):33.
PMID: 39962573
PMC: 11834632.
DOI: 10.1186/s40360-025-00842-1.
Wechsler M, Wells J
ERJ Open Res. 2024; 10(5).
PMID: 39319045
PMC: 11417604.
DOI: 10.1183/23120541.00177-2024.
Yuan Q, Xiao L, Zhang Y, Li L, Xia T, Xu Q
Int J Chron Obstruct Pulmon Dis. 2024; 19:1971-1987.
PMID: 39247667
PMC: 11379031.
DOI: 10.2147/COPD.S471068.
Song Y, Bai X, Ma J
PLoS One. 2024; 19(6):e0303286.
PMID: 38875233
PMC: 11178193.
DOI: 10.1371/journal.pone.0303286.
Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC.
Gemes N, Balog J, Neuperger P, Schlegl E, Barta I, Fillinger J
Front Immunol. 2024; 14:1297577.
PMID: 38187374
PMC: 10770259.
DOI: 10.3389/fimmu.2023.1297577.
Association of T cell infiltration and morphological change of thymus gland with the aggravation of pulmonary emphysema in testosterone deficiency.
Aono K, Matsumoto J, Matsumoto T, Koga M, Migita K, Tominaga K
Biochem Biophys Rep. 2023; 34:101489.
PMID: 37250981
PMC: 10220313.
DOI: 10.1016/j.bbrep.2023.101489.
Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis.
Zhang C, Zhu W, Meng Q, Lian N, Wu J, Liu B
Ann Transl Med. 2023; 10(23):1279.
PMID: 36618788
PMC: 9816841.
DOI: 10.21037/atm-22-5632.
Effect of physical training on cytokine expression in CD4+ T lymphocytes in subjects with stable COPD.
Uzeloto J, de Toledo-Arruda A, Silva B, Braz A, de Lima F, Grigoletto I
Ther Adv Respir Dis. 2022; 16:17534666221091179.
PMID: 35695009
PMC: 9189509.
DOI: 10.1177/17534666221091179.
The Immune Response in Adipocytes and Their Susceptibility to Infection: A Possible Relationship with Infectobesity.
Lopez-Ortega O, Moreno-Corona N, Cruz-Holguin V, Garcia-Gonzalez L, Helguera-Repetto A, Romero-Valdovinos M
Int J Mol Sci. 2022; 23(11).
PMID: 35682832
PMC: 9181511.
DOI: 10.3390/ijms23116154.
Biomarkers, Clinical Course, and Individual Needs in COPD Patients in Primary Care: The Study Protocol of the Stockholm COPD Inflammation Cohort (SCOPIC).
Lundh L, Larsson K, Linden A, Montgomery S, Palmberg L, Sandelowsky H
Int J Chron Obstruct Pulmon Dis. 2022; 17:993-1004.
PMID: 35528148
PMC: 9075012.
DOI: 10.2147/COPD.S358056.
Isorhamnetin Alleviates Airway Inflammation by Regulating the Nrf2/Keap1 Pathway in a Mouse Model of COPD.
Xu Y, Li J, Lin Z, Liang W, Qin L, Ding J
Front Pharmacol. 2022; 13:860362.
PMID: 35401244
PMC: 8988040.
DOI: 10.3389/fphar.2022.860362.
Methylation of SERPINA1 gene promoter may predict chronic obstructive pulmonary disease in patients affected by acute coronary syndrome.
Rotondo J, Aquila G, Oton-Gonzalez L, Selvatici R, Rizzo P, De Mattei M
Clin Epigenetics. 2021; 13(1):79.
PMID: 33858475
PMC: 8048251.
DOI: 10.1186/s13148-021-01066-w.
Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product "Exo-d-MAPPS" in Attenuation of Chronic Airway Inflammation.
Harrell C, Miloradovic D, Sadikot R, Fellabaum C, Markovic B, Miloradovic D
Anal Cell Pathol (Amst). 2020; 2020:3153891.
PMID: 32257769
PMC: 7109559.
DOI: 10.1155/2020/3153891.
Therapeutic Targeting Steroid Resistant Pro-Inflammatory NK and NKT-Like Cells in Chronic Inflammatory Lung Disease.
Hodge G, Hodge S
Int J Mol Sci. 2019; 20(6).
PMID: 30917554
PMC: 6471110.
DOI: 10.3390/ijms20061511.
Impact of one versus two doses of mesenchymal stromal cells on lung and cardiovascular repair in experimental emphysema.
Poggio H, Antunes M, Rocha N, Kitoko J, Morales M, Olsen P
Stem Cell Res Ther. 2018; 9(1):296.
PMID: 30409216
PMC: 6225700.
DOI: 10.1186/s13287-018-1043-6.
Role of inflammatory cells in airway remodeling in COPD.
Wang Y, Xu J, Meng Y, Adcock I, Yao X
Int J Chron Obstruct Pulmon Dis. 2018; 13:3341-3348.
PMID: 30349237
PMC: 6190811.
DOI: 10.2147/COPD.S176122.
Morphometric analysis of mitochondria in lymphocytes of patients with exacerbations of chronic obstructive pulmonary disease - pilot study.
Bialas A, Liberski P, Zielinska A, Kumor-Kisielewska A, Szewczyk K, Milkowska-Dymanowska J
Int J Chron Obstruct Pulmon Dis. 2018; 13:2313-2318.
PMID: 30104871
PMC: 6072681.
DOI: 10.2147/COPD.S163249.
Chronic obstructive pulmonary disease (COPD): neutrophils, macrophages and lymphocytes in patients with anterior tuberculosis compared to tobacco related COPD.
Guiedem E, Ikomey G, Nkenfou C, Walter P, Mesembe M, Chegou N
BMC Res Notes. 2018; 11(1):192.
PMID: 29580274
PMC: 5869764.
DOI: 10.1186/s13104-018-3309-6.
Effect of an Exercise Program on Lymphocyte Proliferative Responses of COPD Patients.
Fernandes J, da Silva C, da Silva A, Pinto R, Duarte A, Carvalho C
Lung. 2018; 196(3):271-276.
PMID: 29525851
DOI: 10.1007/s00408-018-0107-9.